Galectin Therapeutics completes warrant exercise

Galectin Therapeutics Inc. (NASDAQ:GALT), Norcross, Ga. Business: Cancer, Hepatic Date completed: 10/17/13 Type: Warrant exercise Raised: $900,000 Shares: 300,000 Price: $3 Shares after offering: 18 m...